Excellence in clinical research from A to Z

Scroll down ⇩

About us

AtoZ-CRO GmbH is a full-service clinical research organisation (CRO) located in Overath near Cologne, Germany, with over 30 years of experience in clinical development and clinical study management. As a specialist for Germany, Europe, the US, and India, AtoZ-CRO offers a broad range of professional services and partner solutions for international clinical studies with pharmaceuticals and medical devices.


From its head office located in Overath, Germany, AtoZ-CRO manages and coordinates clinical studies of phase 0 through phase IV for national and international clients. The company forms a team of 35 highly experienced and dedicated industry professionals and medical specialists ensuring high standards in clinical study management. AtoZ-CRO is affiliated with a leading initiator of phase I studies in Warsaw, Poland.


Based on the company’s long-established international experience in clinical trial management and cooperation with high-rated business partners, AtoZ-CRO is proud to offer a broad range of services covering all clinical research needs, in particular for small and mid-sized pharmaceutical, biotech, and medical device companies.

Clinical Studies 

Contact us

Clinical Studies

Clinical Studies Phases 0 – IV

  • Planning of clinical studies
  • Preparation of study protocols
  • Design and implementation of CRFs (case report forms) and eCRFs
  • Processing of applications for ethical votes and permissions (e.g. CTA, IND)
  • Regulatory affairs issues
  • Legal EU representative

Other services

  • Monitoring
  • Post-marketing studies

-  NIS

-  PASS

-  Epidemiology

  • Pharmacovigilance
  • Biometry
  • Medical Writing and Translations

About us

Contact us

Contact us

AtoZ-CRO GmbH

Hauptstr. 77
51491 Overath
Tel: 02206 95 99 0
Fax: 02206 820 63
Email: info@atoz-cro.de
www.atoz-cro.de

Business Development

Alexa Foltin-Mertgen, M.Sc.
Email: a.foltin-mertgen@atoz-cro.de

Back to top ⇧

Go to article: Home | Disposable DiagnosticsGo to article: In this issueGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: ContentsGo to article: ElectroCraft Company InsightGo to article: ElectroCraftGo to article: The medical industry briefingGo to article: Omnetics Connector Corporation Company InsightGo to article: NewsGo to article: MikronGo to article: US launches first vision and eye health surveillance systemGo to article: NSFGo to article: Maraca InternationalGo to article: Growing need for diabetes management drives market innovationGo to article: MPS Microsystems Company InsightGo to article: MPS MicrosystemsGo to article: ESC Congress 2018: virtual care at the heart of CVD managementGo to article: ARPA Company InsightGo to article: ARPAGo to article: Could deep brain stimulation help regulate insulin for diabetics?Go to article: Maxon MotorGo to article: Art of TechnologyGo to article: Six tech giants sign health data interoperability pledgeGo to article: AtoZ-CRO GmbHGo to article: Erdmann Design SwitzerlandGo to article: Wireless charging: the breakthrough medical devices are waiting for?Go to article: Protomatic Company InsightGo to article: Protomatic MedicalGo to article: Healthcare in the Home: How VisitHealth is using tech to help GPs better diagnose patientsGo to article: Mecmesin Company InsightGo to article: MecmesinGo to article: Disposable diagnostics: fighting antimicrobial resistance in the field Go to article: Accurate Biometrics - Insight PageGo to article: Accurate Biometrics - Interactive PageGo to article: Organs on a Stick: the growing potential of human organ systems Go to article: Red Rapids Company InsightGo to article: Red RapidsGo to article: Inside Costa Rica’s super-sized medical device sectorGo to article: Röchling Medical NeuhausGo to article: Micro Systems TechnologiesGo to article: Overcoming barriers to digital transformation in R&DGo to article: Euroquartz Company InsightGo to article: EventsGo to article: Velixx Company InsightGo to article: VelixxGo to article: Event: Deep Learning in Healthcare SummitGo to article: FreudenbergGo to article: Next issueGo to article: Aerotech